Thrivent Partner Healthcare Portfolio
Data updated: 2026-08-26
C000062736 — Thrivent Partner Healthcare Portfolio. United States Large Cap Blend / Core Health Care Equity. Holdings, fees, performance and SEC filings.
C000062736 Fund Overview
Thrivent Partner Healthcare Portfolio is a US mutual fund managed by Thrivent Series Fund Inc, categorised as United States Large Cap Blend / Core Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Thrivent Series Fund Inc
- Category: United States Large Cap Blend / Core Health Care Equity
- Assets under management: $237.35M
- 1-year return: 17.5%
- SEC CIK: 0000790166
- SEC series ID: S000021867
- Share class ID: C000062736
C000062736 Investment Objective and Strategy
Thrivent Partner Healthcare Portfolio describes its objective and strategy as follows, from its latest prospectus filed with the SEC by Thrivent Series Fund Inc.
Investment objective
"Thrivent Healthcare Portfolio (the ""Portfolio"") seeks long-term capital growth."
Principal investment strategy
Under normal circumstances, the Portfolio invests at least 80% of its net assets (plus the amount of any borrowing for investment purposes) in the securities of companies that are engaged in the development, production or distribution of pharmaceutical, generic, biotechnology and medical technology products or services (healthcare companies). Healthcare companies are those that derive at least 50% of their annual revenues from the production of such products and provision of such services or have at least 50% of their assets in such products or services. The Portfolio invests primarily in equity securities of both U.S. and non-U.S. companies (including American Depositary Receipts and issuers in emerging markets). In addition, the Portfolio concentrates its investments in the securities of companies in the healthcare industry, some of which may be small- and medium-sized companies.
Should the Adviser determine that the Portfolio would benefit from reducing the percentage of its assets invested in the securities of healthcare companies from 80% to a lesser amount, it will notify you at least 60 days prior to the change. The Adviser considers a variety of factors when choosing investments for the Portfolio, including (i) identifying companies and industries that appear to have the potential for above-average returns; and (ii) identifying companies that are expected to show above-average growth over the long-term, as well as those that appear to be trading below their true worth. The Portfolio will generally sell a stock when, in the opinion of the Adviser, the stock reaches its price target or if there is deterioration in the companys fundamentals, a change in macroeconomic outlook, technical deterioration, valuation issues, a need to rebalance the Portfolio or a better opportunity elsewhere.
C000062736 Holdings
Top 10 holdings of Thrivent Partner Healthcare Portfolio by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Eli Lilly And Company | 15.76% |
| Johnson & Johnson | 9.03% |
| Abbvie, Inc. | 6.84% |
| Unitedhealth Group, Inc. | 6.72% |
| Merck & Co., Inc. | 4.19% |
| Stryker Corporation | 3.79% |
| Danaher Corporation | 3.21% |
| Amgen, Inc. | 2.91% |
| Labcorp Holdings, Inc. | 2.57% |
| Cencora, Inc. | 2.43% |
C000062736 Portfolio Allocation
Asset-class allocation of Thrivent Partner Healthcare Portfolio by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.0% |
| Other | 0.8% |
| Cash & Equivalents | 0.1% |
C000062736 Performance
Total returns for C000062736 (as of 2026-10-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | 2.7% |
| 1 year | 17.5% |
| 3 years (annualised) | 6.1% |
| 5 years (annualised) | 3.6% |
C000062736 Risk Information
Risk metrics for C000062736, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 16.1%
C000062736 Costs and Fees
C000062736 costs about $92 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.92%
- Gross expense ratio: 0.92%
- Portfolio turnover: 17%
- Brokerage commissions: 1.36 bps of average net assets (SEC N-CEN)
C000062736 Cashflows
Over the 12 months to 2026-06, Thrivent Partner Healthcare Portfolio had net outflows of $31.20M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-06 | $1.73M |
| 2026-05 | −$1.31M |
| 2026-04 | −$2.15M |
| 2026-03 | −$2.57M |
| 2026-02 | −$1.84M |
| 2026-01 | −$4.28M |
C000062736 Debt Constituents
No individual debt constituents are reported in Thrivent Partner Healthcare Portfolio's latest SEC N-PORT filing.
C000062736 Prospectus and SEC Filings
Official Thrivent Partner Healthcare Portfolio filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2026-04-29
- Prospectus (485BPOS) — filed 2025-04-29
- Prospectus (485BPOS) — filed 2024-04-29
- Portfolio holdings (N-PORT) — filed 2026-08-26
- Portfolio holdings (N-PORT) — filed 2026-05-28
- Portfolio holdings (N-PORT) — filed 2026-02-26
- Annual census (N-CEN) — filed 2026-03-11
- Annual census (N-CEN) — filed 2025-03-11
Related Funds
Other United States Large Cap Blend / Core Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.